Journal of Advanced Pharmaceutical Research (JAPR) is an on line open access international journal committed to the timely publication of peer-reviewed articles in pharmaceutical sciences. JAPR requires all authors to comply with current ethical standards for publication in their disciplines. Manuscripts submitted to the journal must represent reports of original research, and the original data must be available for review by the editor if necessary. All authors of a manuscript must have agreed to its submission and are responsible for its content, including appropriate citations and acknowledgments, and must also have agreed that the corresponding author has the authority to act on their behalf in all matters pertaining to publication of the manuscript. By submission of a manuscript to the journal, the authors guarantee that they have the authority to publish the work and that the manuscript, or one with substantially the same content, was not published previously, and is not being considered for publication elsewhere. When submitting papers for publication, it is expected that the authors will provide written assurance and describe the novelty of their work or in the approach taken in their research in a covering letter. Authors are advised to refer the publication ethics policies for medical journals published by the World Association of Medical Editors (WAME), posted at http://wame.org/resources/ethics-resources.
Submission of manuscripts
The electronic version of original manuscript saved as Microsoft Word document (.doc) can be sent by e-mail to the editor-in-chief (firstname.lastname@example.org).
All manuscripts are anonymously reviewed by the members of the editorial board and qualified reviewers. When a manuscript is submitted to the journal, it is given a number and assigned to two reviewers. The reviewers are expected to complete their reviews quickly. Manuscripts that have been rejected, or withdrawn after being returned for modification, may be resubmitted if the major criticisms have been addressed. The cover letter must state that the manuscript is a resubmission, and the former manuscript number should be provided.
Though there is no page limit for articles, they should be concised and focused. The manuscripts should be submitted with a cover letter declaring that the study was conducted in compliance with international, national and institutional regulations pertaining to animal experiments and clinical studies. It should also be clearly stated that the study protocol complies with a particular recommendation and is approved for use. The cover letter should explicitly state that the manuscript has not been previously published in any language anywhere and that it is not under simultaneous consideration by another journal. Authors must describe in a covering letter, when submitting papers for publication, the novelty of their work or in the approach taken in their research. The manuscripts must be type-written in clear, grammatically correct english with no typographical errors. Manuscripts that do not meet the minimal requirements for English grammar and composition will be rejected immediately. The corresponding author’s email address must be listed on the title page of the manuscript as all correspondence will be by email. Authors are responsible for obtaining permission to reproduce copyrighted material from other sources and are required to sign an agreement for the transfer of copyright to the publisher. All accepted manuscripts, artwork, and photographs become the property of the publisher. All parts of the manuscript should be typewritten in “Times New Roman font” using a font size of 12, double-spaced, with margins of at least one inch on all sides. Manuscript pages should be numbered consecutively throughout the paper. Authors should also supply a shortened version of the title suitable for the running head, not exceeding 50 character spaces. The manuscript should be prepared and numbered consecutively as follows: Title page, Abstract, Introduction, Materials and methods, Results and discussion, Conclusion, Acknowledgements, References, Figure legends, Tables and Figures. Leave one space after a comma, except in chemical names, for example, 1,2,3,4- tetramethyl. For the units of measurement, the use of the International System of Units (SI) is recommended: m (meter), g (gram), kg (kilogram), μg (microgram), s (second), min (minute), h (hour), d (day), y (year), l (litre), μl (microlitre), ng/ml not ng•ml-1 and r/min not rpm. Excessive abbreviations should be avoided and abbreviations other than those acknowledged, should be contained in brackets at their first use.
New, significant, innovative and original findings are suitable as Research papers.
Please give the title (Title Case; capital for first character), running title (not to exceed 50 characters and spaces), full name of each author and an asterisk placed after the name of the corresponding author, address(es) of the institution(s) at which the work was performed, each author’s affiliation, and a footnote including the complete mailing address, a single telephone number, a single fax number, and a single e-mail address for the corresponding author.
An abstract not exceeding 250 words(a single paragraph) should be provided.Avoid abbreviations and references, and do not include diagrams in abstract. The abstract with keywords should be typed on a separate sheet.
Below the abstract, type 3-6 keywords or short phrases suitable for indexing.
The introduction should not be an extensive literature review although it should provide sufficient background information for the reader to understand and evaluate the results of the present study without referring to previous publications on the same topic.
Materials and methods:
The section should include sufficient technical information to allow the experiments to be repeated. Procedural detail that has been published previously should be referred to by citation. When a modified procedure is used, only the author's modifications of the previously published method need to be given in detail.
Results and discussion:
Results should be described as concisely as possible in one of the following ways: text, table(s), or figure(s). Avoid extensive use of graphs to present data that might be more concisely or more comprehensively presented in the figures or tables. The reproducibility and statistical significance of measurements, material or biological data must be included where relevant. The discussion should provide an interpretation of the results and their significance with regard to previously published work. There should not be any significant repetition of the experimental procedures or reiteration of the introduction.
A short paragraph summarizing the most important finding(s) of the research is required.
The source of any financial support, gifts, technical assistance and advice received for the work being published must be indicated in the Acknowledgments section.
Responsibility for the accuracy of bibliographic citations lies entirely with authors. Citations of literature in the text must be by author and date (Pattnaik, 2010; Pattnaik et al., 2009) and a separate Reference List should be supplied. Prepare reference list in accordance with the following examples:
Cho UJ, Choi HK. Enhancement of percutaneous absorption of ketoprofen: effect of vehicles and adhesive matrix. Int. J. Pharm. 1998, 169 (1), 95-104.
Myers RH, Montgomery DC. Response Surface Methodology: Process and Product Optimization Using Designed Experiments; John Wiley & Sons: New York, NY, 1995.
Contribution to a Book:
Barry BW. Percutaneous absorption. In Dermatological Formulations; Barry BW, Ed.; Marcel Dekker, Inc.: New York, 1983; 49-94.
All tables must be numbered consecutively (using Arabic numerals) and be cited in the text. Titles should be short but descriptive. Each table should be on a separate sheet, together with a legend and/or footnotes identified by superscripts a, b, c, etc. Do not use vertical lines and keep horizontal rules to a minimum.
Figures (photographs, drawing, and charts/graphs) are to be numbered in one consecutive series of Arabic numerals in the order in which they are cited in the text. The captions for figures should be typed on a separate sheet of paper under “Figure Legends”. The width of the figure should be about 8 cm or 16 cm (but not more than 16 cm) and in figures, the font of words must be of “Times New Roman” with font size of 9 pt, which especially for the X-axis and Y-axis.
Formula and equations:
Structural and chemical formula, process flow diagrams and complicated mathematical expressions should be very clearly presented. All subscripts, Greek letters and unusual characters must be identified. Structural and chemical formulae as well as process flow diagrams should be prepared in the same way as graphs.
The maximum length of review articles should be 20 double spaced pages and contain up-to-date information providing comprehensive coverage of relevant literature. Review articles should preferably be written by scientists who have in-depth knowledge of the topic and have significant contribution documented by research publications. All format requirements are similar to those applicable to Research papers. Review articles need not be divided into sections such as materials and methods, and Results and discussion, but should definitely have an abstract and introduction.
To maintain and protect the Society’s ownership and rights and to provide scientists the opportunity to publish in high-quality journals, Journal of Advanced Pharmaceutical Research (JAPR) requires the corresponding author to sign a copyright transfer agreement on behalf of all the authors. Unless this agreement is received, the journal will not be able to publish the manuscript. The format of the copyright agreement may be downloaded from the journal site.
Publication Fee and Other Charges
Every article will be charged a nominal cost towards processing, secured data storage system, etc. (Rs.1000 for submissions from India and 50 USD for submissions from outside India).